|
MLL4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.41789999530806E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.0787000004342E-07 |
| Normal-vs-Stage2 |
2.642700E-03 |
| Normal-vs-Stage3 |
3.200500E-04 |
| Normal-vs-Stage4 |
2.990700E-04 |
| Stage1-vs-Stage2 |
8.891400E-01 |
| Stage1-vs-Stage3 |
4.140200E-01 |
| Stage1-vs-Stage4 |
5.932600E-01 |
| Stage2-vs-Stage3 |
6.829800E-01 |
| Stage2-vs-Stage4 |
7.938200E-01 |
| Stage3-vs-Stage4 |
8.613000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62729999997335E-06 |
| Normal-vs-AfricanAmerican |
6.12869999971899E-07 |
| Normal-vs-Asian |
7.798400E-03 |
| Caucasian-vs-AfricanAmerican |
1.316450E-03 |
| Caucasian-vs-Asian |
1.139650E-03 |
| AfricanAmerican-vs-Asian |
1.166200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.25260000003203E-06 |
| Normal-vs-Female |
8.97789997900134E-09 |
| Male-vs-Female |
3.692500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.865600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.82120000191688E-08 |
| Normal-vs-Age(61-80Yrs) |
1.61841999999357E-05 |
| Normal-vs-Age(81-100Yrs) |
1.835840E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.590200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.694600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.944200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.340800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.201000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.249400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.4602987142307E-11 |
| Normal-vs-Grade 2 |
9.33160000049504E-07 |
| Normal-vs-Grade 3 |
1.73376000000003E-05 |
| Normal-vs-Grade 4 |
1.196900E-03 |
| Grade 1-vs-Grade 2 |
4.49060000000667E-05 |
| Grade 1-vs-Grade 3 |
2.25969999999576E-05 |
| Grade 1-vs-Grade 4 |
2.35049999999237E-05 |
| Grade 2-vs-Grade 3 |
5.863000E-01 |
| Grade 2-vs-Grade 4 |
6.602200E-01 |
| Grade 3-vs-Grade 4 |
9.565600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.02869999996091E-06 |
| Normal-vs-ccB subtype |
2.823100E-04 |
| ccA subtype-vs-ccB subtype |
4.199200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.16830000005142E-06 |
| Normal-vs-N1 |
4.239100E-03 |
| N0-vs-N1 |
7.187800E-01 |
|
|
